iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT04206748
- Status
- Recruiting
Conditions
- Gestational Diabetes
- Pregnancy in Diabetic
- Type2 Diabetes
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- iGlucose Smart Meter System — DEVICESubjects will have routine care enhanced by use of theThe iGlucose Smart meter system. This is an example of integration of a SMBG system with internet-based technology; including cell phone notifications for reminders, feedback, and communication with clinicians
- Routine Care-RX meter — DEVICESubjects will receive routine care with the insurance prescribed glucose meter. They will self manage with traditional diabetes diary.
Study Details
The purpose of this study is to investigate whether automation of glucose monitoring data to facilitate the total number of recommended and completed SMBG checks improve clinical outcomes for women living with gestational and type 2 diabetes during pregnancy? This is a RCT
Key Dates
- Start date
- Nov 12, 2019
- Status verified
- Sep 2021
- Primary completion
- Nov 12, 2021
- Completion
- Nov 1, 2022
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: iGlucose Smart Meter
- Placebo Comparator: Rx glucose meter
Primary Outcome Measure
Neonatal morbidity [ Time Frame: at the time of discharge (about 2-7 days after birth) ]
Central Contacts
- Joycelyn Corthwaite, RD832-325-7205
- Clara Ward, MD713-500-6412
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research PlanEARLY_PHASE1 · Recruiting · The University of Texas Health Science Center at San Antonio · San Antonio, Texas
- A Causative Role for Amylin in Diabetic Peripheral NeuropathyRecruiting · Zabeen Mahuwala, MD · Lexington, Kentucky
- Immediate Postpartum Glucose Tolerance TestingRecruiting · MemorialCare Health System · Long Beach, California
- DETERMINE: Detemir vs NPHPHASE2 · Recruiting · University of California, Los Angeles · Los Angeles, California